Sculptra in Seoul

Sculptra is a collagen biostimulator, not a hyaluronic-acid filler. Unlike conventional fillers — which can sometimes look unnatural when overused — Sculptra works by triggering your own collagen regeneration over weeks, producing a more natural appearance. Sculptra and HA fillers are not injected at the same session, but they can be combined in a staged plan, with each layer placed at a different tissue depth and a clinical interval between sessions.

Sculptra is appropriate when the main goal is support and gradual collagen-focused change — typically for patients with early volume loss, cheek/temple deflation, or skin laxity that needs underlying scaffold rebuilding. Skin boosters (Rejuran, Skinvive, Profhilo) work on a different layer: they target hydration, fine texture, and skin quality without addressing volume or laxity. Many international patients receive both — Sculptra for structure plus a skin booster series for surface quality — over a 2-3 month staged plan.

Sculptra works gradually. Mild swelling lasts 24-72 hours, then a quiet period of 4-8 weeks before visible change begins as fibroblast-driven neocollagenesis activates. Peak results emerge at 3-6 months after the final session, when type I collagen remodeling is maximal. Durability is typically about 24 months after a full course, supported by the Narins 2010 randomized trial which documented sustained correction through 25 months (PMID 20159311). A maintenance session every ~2 years is typical.

Following injection, patients massage each treated area for 5 minutes, 5 times per day, for 5 days starting day 3. This protocol ensures even PLLA microparticle distribution in the dermis and substantially reduces nodule risk. Modern high-dilution reconstitution (7-9 mL per vial) combined with the 5-5-5 rule has dropped published nodule rates from 10-44% (early HIV lipoatrophy protocols with low dilution, Valantin 2003) into the low single digits today (Fitzgerald, Graivier, Kane, Lorenc panel consensus, PMID 20844300). Skipping the massage protocol is the single most common cause of palpable nodules.

Good candidates are typically patients aged 35-65 with early-to-moderate facial volume loss (cheek deflation, temple hollowing, jawline support) who prefer gradual natural change over a one-session transformation. Sculptra is NOT appropriate for lips or directly under the eyes. Contraindications include active skin infection in the area, autoimmune connective-tissue disease, keloid-prone skin, pregnancy or lactation, and known hypersensitivity to PLLA or lidocaine. Patients on rapid weight-loss medications (GLP-1 agonists like Ozempic) are often excellent candidates because Sculptra's original FDA indication was HIV-associated facial fat loss — analogous deflation pattern, well-studied response (Carey 2009 HIV Medicine 48-week follow-up, PMID 19245538).

HA filler typically lasts 9-18 months depending on the product and site; Sculptra's collagen scaffold persists for approximately 24 months after a full course. Over a 2-year window, HA filler patients typically have 1-2 top-up sessions while Sculptra patients complete the initial 3-session course and a single maintenance session at ~24 months. Per-session cost is similar, but the per-month equivalent often favors Sculptra for patients prioritizing longevity over reversibility. We discuss the full 24-month cost projection during consultation rather than quoting a single-session price out of context.

A typical international Sculptra patient plans either (a) the first session during a Seoul trip with subsequent sessions back home if their local dermatologist offers the protocol, or (b) two visits to Seoul approximately 4-6 weeks apart, with the final session either locally or on a third trip. Per visit, plan one consultation day + one treatment day + one downtime day (3 days minimum). Patients with one short trip available will hear an honest recommendation that Sculptra may not be the best fit and that a different category (HA filler for immediate visible change, or a skin booster series with home-care continuation) may serve them better. We do not push Sculptra onto patients whose travel timing doesn't support it.